BofA lowered the firm’s price target on Crocs (CROX) to $98 from $99 and keeps a Buy rating on the shares. Q2 was “disappointing,” but the firm sees a path toward revenue growth bottoming out in Q3 and improving into 2026, says the analyst, who expects management to hit Q3 guidance and expects Crocs brand revenues to sequentially improve in Q4 driven by better international results. The firm is modestly lowering its FY25 EPS estimate by 1% to $11.30 to reflect forex and lower Heydude revenues in Q4, the analyst noted.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CROX:
- Optimistic Outlook for Crocs: Buy Rating Affirmed Amid Anticipated Revenue Rebound and Strategic Leadership
- Crocs Faces Challenges in Sales and Margins Amidst Rising Competition and Product Strategy Concerns
- Crocs downgraded to Negative from Mixed view at BWG Global
- Crocs Stock (CROX) Jumps on New Sydney Sweeney Ad Campaign
- Pfizer to acquire Metsera, Oracle names new CEOs: Morning Buzz